Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2017
Price : $35 *
At a glance
- Drugs Gadobenic acid (Primary) ; Gadoxetate disodium (Primary)
- Indications Hepatic tumours; Liver disorders
- Focus Diagnostic use
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2016.
- 29 Apr 2016 Planned End Date changed from 1 Aug 2019 to 1 Aug 2018.